MedTrace Logo

Treatment Recommendations for Patients With ADHD TDApp2

NCT05651685 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2024-07-01

No results posted yet for this study

Summary

The purpose of this study is to compare the recommendations made by TDApp2 with those by relevant clinical practice guidelines in children/adolescents with ADHD.

Conditions

  • Attention Deficit Disorder With Hyperactivity

Sponsors & Collaborators

  • Institut d'Assistència Sanitària

    collaborator OTHER

  • Universitat de Girona

    lead OTHER

Principal Investigators

  • Xavier Castells · Universitat de Girona

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-12
Primary Completion
2024-06-28
Completion
2024-06-28

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05651685 on ClinicalTrials.gov